Literature DB >> 33124907

An Uncommon Cause of Bronchial Obstruction.

John W Frey1, Charles D Bengtson1, Nirmal K Veeramachaneni2, Kyle R Brownback1.   

Abstract

Year:  2020        PMID： 33124907      PMCID： PMC7640715          DOI： 10.1513/AnnalsATS.202002-140CC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  10 in total

1.  Pseudomembranous necrotizing bronchial aspergillosis in a renal transplant recipient.

Authors:  A Sayiner; S Kürşat; H Töz; S Duman; B Onal; E Tümbay
Journal:  Nephrol Dial Transplant       Date:  1999-07       Impact factor: 5.992

2.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Authors:  Robert Timmerman; Ronald McGarry; Constantin Yiannoutsos; Lech Papiez; Kathy Tudor; Jill DeLuca; Marvene Ewing; Ramzi Abdulrahman; Colleen DesRosiers; Mark Williams; James Fletcher
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

Review 3.  Commentary: unusual manifestations of aspergillosis.

Authors:  D W Denning
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

Review 4.  Aspergillus tracheobronchitis: report of 8 cases and review of the literature.

Authors:  Mario Fernández-Ruiz; José Tiago Silva; Rafael San-Juan; Begoña de Dios; Ricardo García-Luján; Francisco López-Medrano; Manuel Lizasoain; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2012-09       Impact factor: 1.889

5.  The possibilities of greater omentum usage in thoracic surgery.

Authors:  Y N Levashev; A L Akopov; I V Mosin
Journal:  Eur J Cardiothorac Surg       Date:  1999-04       Impact factor: 4.191

6.  Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis.

Authors:  H Kunst; M Wickremasinghe; A Wells; R Wilson
Journal:  Eur Respir J       Date:  2006-04-12       Impact factor: 16.671

7.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

8.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

9.  Invasive aspergillosis in critically ill patients without malignancy.

Authors:  Wouter Meersseman; Stefaan J Vandecasteele; Alexander Wilmer; Eric Verbeken; Willy E Peetermans; Eric Van Wijngaerden
Journal:  Am J Respir Crit Care Med       Date:  2004-06-30       Impact factor: 21.405

10.  Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases.

Authors:  N Wu; Y Huang; Q Li; C Bai; H-D Huang; X-P Yao
Journal:  Clin Microbiol Infect       Date:  2009-08-18       Impact factor: 8.067
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.